BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 4502173)

  • 1. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
    Priori ES; Wilbur JR; Dmochowski L
    J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 10. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
    Donner L; Triche TJ; Israel MA; Seeger RC; Reynolds CP
    Prog Clin Biol Res; 1985; 175():347-66. PubMed ID: 3991736
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific inhibition of sarcoma-specific cellular immunity by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Int J Cancer; 1973 Mar; 11(2):273-9. PubMed ID: 4524527
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 14. [Special tumors of childhood].
    Harms D; Schmidt D
    Verh Dtsch Ges Pathol; 1986; 70():190-204. PubMed ID: 3030018
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.
    Sinkovics JG; Ahmed N; Hrgovcic MJ; Cabiness JR; Wilbur JR
    Tex Rep Biol Med; 1972; 30(4):347-60. PubMed ID: 4121149
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
    Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical studies of Ewing's sarcomas and their differential diagnosis with other "small round blue cell" sarcomas of childhood and adolescence].
    Llombart-Bosch A; Perez-Bacete M; Triche TJ
    Verh Dtsch Ges Pathol; 1986; 70():321-4. PubMed ID: 3548136
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
    Ravindranath NM; Shuler C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.